Wistar Institute ( Wistar Institute )

Wistar Institute

Wistar Institute's picture

The Wistar Institute is the nation’s first independent institution devoted to medical research and training. The Wistar Institute has evolved from its beginnings as an anatomical teaching museum to its present-day status as an international leader in basic biomedical research.

In 1972, The Wistar Institute was designated a National Cancer Institute Cancer Center in basic research—a distinction it holds to this day.

Wistar discoveries have led to the development of vaccines for rabies, rubella, and rotavirus, the identification of genes associated with breast, lung, and prostate cancer, and the development of monoclonal antibodies and other significant research technologies and tools.

Wistar Institute press release, blog etc

06/28/2018 - 20:00 New Insights into the Epigenetic Control of Hematopoiesis
06/25/2018 - 19:01 Unraveling the Role of a Commonly Mutated Tumor Suppressor in Gene Expression and Ovarian Tumorigenesis
06/13/2018 - 10:05 Older Melanoma Patients Have Better Response to Immune Checkpoint Blockade Therapy
06/07/2018 - 09:34 The Wistar Institute Partners with Nations Top Cancer Centers to Endorse Goal of Eliminating HPV-related Cancers in the United States
06/04/2018 - 11:49 The Wistar Institute and Harbour BioMed Join Forces to Advance Novel Antibody Therapies for Cancer and Infectious Diseases
05/31/2018 - 10:40 How Might Baking Soda Boost Cancer Therapy?
05/30/2018 - 10:45 Wistar Receives Grant from the Jayne Koskinas Ted Giovanis Foundation for Health and Policy to Support the Breast Cancer Research Consortium
04/27/2018 - 11:12 Wistar and Ben Franklin Technology Partners of Southeastern Pa. Forge Collaboration to Accelerate Technology Commercialization
04/25/2018 - 16:23 Targeting Telomerase as a Therapeutic Strategy for Difficult-to-Treat Melanoma
04/19/2018 - 10:02 Coalition for Epidemic Preparedness Innovations Supports MERS & Lassa Enhanced DNA Vaccine Technology to Expedite Vaccine Development
04/19/2018 - 08:48 Wistar Team Receives Prestigious Award from National Clinical Research Forum for DNA-based Zika Research
04/18/2018 - 12:40 Top HIV Cure Research Team Refutes Major Recent Results on How to Identify HIV Persistence
04/17/2018 - 10:41 Wistar Institute Spin-Out ISOMA Diagnostics Secures Seed Funding
04/12/2018 - 11:49 Soluble Antibodies Play Immune Suppressive Role in Tumor Progression
04/12/2018 - 03:07 Back to Press Releases
04/09/2018 - 13:24 PA Department of Labor & Industry Awards Wistar & Philadelphia Works with Grant to Enhance Workforce Training Program with Community College of Philadelphia
03/27/2018 - 09:17 Repurposing Existing FDA-Approved Inhibitors May Provide New Treatment Approach for Ovarian Cancer
03/23/2018 - 11:00 Wistar and YourEncore Unite to Advance Life Sciences Opportunities